November 2025
1. TU G, Wu Q, Yuan Y, Jiang Q, et al
   DNA damage agents trigger iNKT cell-mediated elimination of AML cells through activation of NF-kappaB/HLA-DRB6/CD1d pathway.
   Biochem Pharmacol. 2025;241:117174.
   

   >> Share

   
   July 2025
2. FANG L, Zuo L, Xing F, Wang Y, et al
   Repositioning miconazole: A novel drug for inducing cell death and differentiation in myeloid leukemia.
   Biochem Pharmacol. 2025 Jul 4:117126. doi: 10.1016/j.bcp.2025.117126.
   

   >> Share

   
   
3. DONG S, Yang R, Wang Y, Fang X, et al
   A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway.
   Biochem Pharmacol. 2025;240:117111.
   

   >> Share

   
   March 2025
4. SUN X, Zhang C, Fan B, Liu Q, et al
   Cotargeting of thioredoxin 1 and glutamate-cysteine ligase in both imatinib-sensitive and imatinib-resistant CML cells.
   Biochem Pharmacol. 2025;233:116763.
   

   >> Share

   
   January 2025
5. HAN YU P, Yan Zhang Z, Yuan Kang Y, Huang P, et al
   Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions.
   Biochem Pharmacol. 2025;233:116774.
   

   >> Share

   
   November 2024
6. LIU W, Dou C, Zhang C, Chen P, et al
   PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K/AKT/mTOR pathway through downregulation of GBE1.
   Biochem Pharmacol. 2024 Nov 9:116620. doi: 10.1016/j.bcp.2024.116620.
   

   >> Share

   
   October 2024
7. ZHAO J, Wu S, Wang D, Edwards H, et al
   Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax.
   Biochem Pharmacol. 2024;228:116065.
   

   >> Share

   
   
8. XIE N, Zhong L, Liu L, Fang Y, et al
   Corrigendum to "Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells" [Biochem. Pharmacol. 89/1 (2014) 74-85].
   Biochem Pharmacol. 2024;230.
   

   >> Share

   
   June 2024
9. CHIOU JT, Lee YC, Huang CH, Wang LJ, et al
   Corrigendum to "Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells" [Biochem. Pharmacol.188 (2021) 114544].
   Biochem Pharmacol. 2024;226:116359.
   

   >> Share

   
   May 2024
10. SUN L, Rao S, Kerim K, Lu J, et al
    A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation.
    Biochem Pharmacol. 2024;225:116262.
    

    >> Share

    
    April 2024
11. CHIOU JT, Chang LS
    ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Biochem Pharmacol. 2024;224:116242.
    

    >> Share

    
    March 2024
12. DI GIORGIO C, Morretta E, Lupia A, Bellini R, et al
    Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
    Biochem Pharmacol. 2024;223:116134.
    

    >> Share

    
    February 2024
13. HURRISH KH, Su Y, Patel S, Ramage CL, et al
    Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
    Biochem Pharmacol. 2024;220:115981.
    

    >> Share

    
    November 2023
14. CHIOU JT, Lee YC, Chang LS
    Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
    Biochem Pharmacol. 2023 Nov 19:115934. doi: 10.1016/j.bcp.2023.115934.
    

    >> Share

    
    October 2023
15. HAN H, Zhao C, Liu M, Zhu H, et al
    Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia.
    Biochem Pharmacol. 2023 Oct 21:115875. doi: 10.1016/j.bcp.2023.115875.
    

    >> Share

    
    September 2023
16. OIKONOMOU A, Valsecchi L, Quadri M, Watrin T, et al
    High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
    Biochem Pharmacol. 2023 Sep 15:115809. doi: 10.1016/j.bcp.2023.115809.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share